Pharmaq signs financing of leveraged buy-out
Norwegian pharmaceutical company Pharmaq has signed a new Nkr815m ($139.6m) debt package. The senior credit facilities will serve to support private equity firm Permira’s acquisition of Pharmaq, refinance existing debt, and are also for general corporate purposes.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
